YahooSeptember 3, 2026 at 12:54 PM NYyesterday

ABBV Stock Has Returned $62 Billion To Shareholders. Should You Care?

A pharma giant delivered substantial cash returns to shareholders while outperforming the broader market. Here is a breakdown of AbbVie's cash-return capacity, and the key commercial metric supporting its durability.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Read at Source

Companies in This Story

BMYBristol-Myers Squibb Co66.83− 1.85%

Companies in This Story

Related Stories